Wednesday, 12 October 2016

Case 1: A Patient with Disease Progression on Hydroxyurea - Targeted Oncology


Case 1: A Patient with Disease Progression on Hydroxyurea
Targeted Oncology
Either there is increased risk of phlebotomy, or there is a real need for phlebotomy, that means the red blood cells are starting to grow without control despite the optimal dose of hydroxyurea. There is a progressive leukocytosis, or platelets start ...



from phlebotomy - Google News http://bit.ly/2dJcFWC

No comments:

Post a Comment